2016
DOI: 10.1001/jamapsychiatry.2015.3375
|View full text |Cite
|
Sign up to set email alerts
|

Mediation of Developmental Risk Factors for Psychosis by White Matter Microstructure in Young Adults With Psychotic Experiences

Abstract: IMPORTANCE White matter (WM) abnormalities have been identified in schizophrenia at the earliest stages of the disorder. Individuals in the general population with psychotic experiences (PEs) may show similar changes, suggesting dysfunction due to aberrant neurodevelopment. Studying such people is a powerful means of understanding the nature of neurodevelopmental problems without the confound of clinical management and allows other potential risk factors associated with the schizophrenia spectrum to be taken i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
30
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 38 publications
(32 citation statements)
references
References 120 publications
1
30
0
1
Order By: Relevance
“…Previous studies based on the ALSPAC cohort, a prospective general population cohort based in the Bristol area in South West England, have shown subgroups of subjects who developed psychotic disorder (PD) and psychotic experiences (PEs) [24] at age 18. These groups showed alterations in cortical white matter microstructure [25], working memory [26], and raised inflammatory markers in childhood [12] in subjects with PE at age 18. We recently used discovery methods to compare the plasma proteome of age 12 subjects who developed psychotic disorder at age 18 and we found evidence implicating some protein members of the complement pathway at age 12 in subjects with PD at age 18 [27].…”
Section: Introductionmentioning
confidence: 95%
“…Previous studies based on the ALSPAC cohort, a prospective general population cohort based in the Bristol area in South West England, have shown subgroups of subjects who developed psychotic disorder (PD) and psychotic experiences (PEs) [24] at age 18. These groups showed alterations in cortical white matter microstructure [25], working memory [26], and raised inflammatory markers in childhood [12] in subjects with PE at age 18. We recently used discovery methods to compare the plasma proteome of age 12 subjects who developed psychotic disorder at age 18 and we found evidence implicating some protein members of the complement pathway at age 12 in subjects with PD at age 18 [27].…”
Section: Introductionmentioning
confidence: 95%
“…White matter abnormalities are diffuse in subjects with schizophrenia, with globally decreased levels of fractional anisotropy (FA) and increased radial diffusivity (RD) (Chavarria‐Siles et al, ; Reid et al, ), proxy measures for myelin integrity. Deficits are evident diffusely in frontomedial white matter tracts (Drakesmith et al, ), orbitofrontal cortex, posterior parietal cortex (Green et al, ), arcuate fasciculus, cingulum bundle, and inferior longitudinal fasciculus (Oestreich et al, ; Seitz et al, ). The apparently more global disruptions to white matter in schizophrenia compared to other neuropsychiatric disorders are consistent with the more severe and complex nature of dysfunction in schizophrenia.…”
Section: Psychiatric Disordersmentioning
confidence: 99%
“…Disrupted white matter structure is likely to precede the onset of FEP (2). In adolescent cohorts within the general population, alterations in white matter structure associated with a psychotic experience can be observed before diagnosis of a mental health condition (3,10). This suggests that an aberrant neurodevelopmental risk state, centered on a structural vulnerability that compromises functional connectivity, can predispose to psychotic symptoms, which in some individuals may progress to a diagnosed disorder.…”
Section: Psychosis As a Neurodevelopmental Dysconnectivity Risk Syndromementioning
confidence: 99%
“…Correspondingly, structural abnormalities in white matter tracts across the brain are observed in postmortem studies (7) and in vivo noninvasive imaging using diffusion-weighted magnetic resonance imaging (MRI) (2,8,9). It is likely that white matter changes are present even before the experience of active symptoms at the onset of firstepisode psychosis (FEP), preceding pharmacological treatment with neuroleptic medications (2,3,10).…”
mentioning
confidence: 99%